Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by CMS Cameron McKenna Nabarro Olswang LLP ordered by Published Date Descending.
Links to Result pages
1 2  
Upcoming CFDA Inspection On Class I And Class II Medical Devices Manufacturers
Circular (2014) No.15 provides for the specific deadlines for different domestic medical devices manufacturing companies to gradually meet the Medical Devices Manufacturing Quality Management Standards
9 Jan 2018
Budget 2012 - Impact On The Lifesciences Sector
The Budget included good news for the lifesciences sector. While nothing groundbreaking was announced, in general it maintained the course set in the previous year and many positive announcements were made. Importantly the Government restated its commitment to the sector and to its important role in the UK economy.
27 Mar 2012
IP Snapshot April 2011
A portrait photo is afforded copyright protection under Article 6 of Directive 93/98 and of Directive 2006/116 if it is an original work resulting from the intellectual creation of the photographer, which is the case where the photographer ‘leaves his mark’.
3 May 2011
Advocate General Considers The Meaning Of The Term ‘Human Embryos’
The Advocate General has published an opinion concerning the interpretation of certain terms contained in Directive 98/44/EC, the "Biotech Directive".
23 Mar 2011
Reform Of Corporation Tax For Lifesciences Companies - A Chance To Have Your Say
Lifesciences companies have until 22 February 2011 to respond to a Government consultation on a number of important reforms to UK corporation tax which could have a significant impact on the sector.
26 Jan 2011
More EU Monitoring Of Patent Settlements In The Pharma Sector
On 17 January 2011, the European Commission announced that it has launched another round of its monitoring of patent settlement agreements between pharmaceutical companies.
24 Jan 2011
Advocate General Gives Opinion in L’Oreal v eBay Reference
In November 2009 we reported in an earlier Law Now, that Justice Arnold had referred a number of questions to the ECJ for preliminary reference in the L’Oreal v eBay High Court trademark infringement case.
22 Dec 2010
EU Health Claims Approval – New Approach
Following recent controversy in respect of the piecemeal time-scale for appraisal of health claim applications under Regulation 1924/2006, and the length of time taken to review the over 4500 submitted claim applications, DG SANCO has now announced that the European Food Safety Authority ("EFSA") is to issue opinions on all non-botanical, EFSA-generic, article 13(1) health claim applications by late 2011 or early 2012.
21 Oct 2010
AstraZeneca Fine for Abuse of Dominance Largely Upheld by the EU General Court
The EU General Court has mostly upheld the fine imposed by the Commission on AstraZeneca for abuse of dominance in relation to its anti-ulcer medicine Losec/omeprazole.
5 Jul 2010
Referral to ECJ Concerning Supplementary Protection Certificates
The Court of Appeal has recently considered a High Court decision of January 2010 that rejected Medeva’s application for a Supplementary Protection Certificate (SPC) in relation to its combined vaccine product.
29 Jun 2010
Lifesciences - A Legal guide to China (2nd edition)
The CMS, China lifesciences team would like to introduce the 2nd edition of its legal guide to China, a 130 page guide to the lifesciences industry in China fully updated.
10 Jun 2010
New 5-Year Retention Period For Clinical Trial Documents
From 22 March 2010, the period for which sponsors must keep basic documentation of a clinical trial will be extended from two to five years.
15 Mar 2010
EPO Allows Claims For New Dosage Regimes But Rejects 'Swiss Claim' Format
In case G 02/08 The Enlarged Board of Appeal of the European Patent Office recently ruled that where it is already known to use a particular medicament to treat a particular illness, it is still possible to secure patent protection for a new and inventive dosage regime in respect of the same medicament used to treat the same illness.
4 Mar 2010
High Court Provides Clarification On The Application Of The SPC Regulations To Vaccines
The High Court has upheld the decision of the IPO that a Supplementary Protection Certificate (SPC) could not be granted for a combined vaccine product containing more active ingredients than were protected by the basic patent.
2 Mar 2010
Lifesciences Snapshot: Winter 2009
The existing laws on bribery and corruption are complicated as a result of their piecemeal development over more than 100 years.
21 Dec 2009
Lifesciences Snapshot: Winter 2009
A patent for a drug called fluvastatin, used to reduce cholesterol, has been found to be invalid by the High Court on the grounds of obviousness.
16 Mar 2009
New Chinese Patent Law: What Does It Mean For Life Sciences Companies ?
After more than three years of preparation work, the revised PRC Patent Law ("New Patent Law") was finally promulgated on 27 December 2008 and will enter into force on 1 October 2009.
13 Mar 2009
CTPA And ASA Publish Guidance On Claims Made In Cosmetics
Several recent Advertising Standards Authority ("ASA") decisions have illustrated the need for members of the cosmetics industry to be able to substantiate the claims made in relation to their products.
10 Nov 2008
New Civil Sanctions For Lifesciences Companies Operating In The UK
The Regulatory Enforcement and Sanctions Act 2008 (RESA) came into force on 22 July 2008 . This could have significant regulatory compliance implications for lifescience companies or individuals operating in the UK in the medicines, medical devices and diagnostics sectors and also for human tissue establishments.
11 Aug 2008
Lifesciences Snapshot: Summer 2008
Following the deposit by France of the instrument of ratification with the German Ministry of Justice on 29 January, the London Agreement entered into force on 1 May 2008.
30 Jul 2008
Links to Result pages
1 2